Cited 29 time in
In vitro cultivation of Panax ginseng CA Meyer
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Adil, Muhammad | - |
| dc.contributor.author | Jeong, Byoung Ryong | - |
| dc.date.accessioned | 2022-12-26T16:33:28Z | - |
| dc.date.available | 2022-12-26T16:33:28Z | - |
| dc.date.issued | 2018-10-15 | - |
| dc.identifier.issn | 0926-6690 | - |
| dc.identifier.issn | 1872-633X | - |
| dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/11156 | - |
| dc.description.abstract | Ginseng is a perennial plant that grows slowly and has a long production cycle (4-6 years). It belongs to genus Panax that comprises of 11 different species and valued for their immense potential to cure all diseases, especially against fatigue. Korean ginseng is known for its homeostasis, anti-Alzheimer, anti-amnesia and anticancer properties. Since the approval of its medicinal properties through modern scientific technology and increased dependence of the western world on herbal remedies, a surge for Korean ginseng in the international market was seen during last decades. Around the world Korean ginseng have been found to be superior in the content of ginsenosides, non-saponin, phenol and polysaccharide compounds than American and Sanchi ginseng. World ginseng production needs alternative approaches to meet the modern-day market demand for standardized plant products of uniform quality and free of toxic agrochemicals. For the purpose in-vitro tissue culture approaches have extensively been studied and adopted for uniform and continuous supply of the products. This review elaborates on the traditional medicinal uses and cultivation practices of Panax ginseng C.A. Meyer and explains modem day tissue culture approaches for the enhanced production of important medicinal compounds. | - |
| dc.format.extent | 13 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | ELSEVIER | - |
| dc.title | In vitro cultivation of Panax ginseng CA Meyer | - |
| dc.type | Article | - |
| dc.publisher.location | 네델란드 | - |
| dc.identifier.doi | 10.1016/j.indcrop.2018.05.076 | - |
| dc.identifier.scopusid | 2-s2.0-85048561837 | - |
| dc.identifier.wosid | 000442067300031 | - |
| dc.identifier.bibliographicCitation | INDUSTRIAL CROPS AND PRODUCTS, v.122, pp 239 - 251 | - |
| dc.citation.title | INDUSTRIAL CROPS AND PRODUCTS | - |
| dc.citation.volume | 122 | - |
| dc.citation.startPage | 239 | - |
| dc.citation.endPage | 251 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Agriculture | - |
| dc.relation.journalWebOfScienceCategory | Agricultural Engineering | - |
| dc.relation.journalWebOfScienceCategory | Agronomy | - |
| dc.subject.keywordPlus | HIGH-DENSITY CULTIVATION | - |
| dc.subject.keywordPlus | NORTH-AMERICAN GINSENG | - |
| dc.subject.keywordPlus | HAIRY ROOT CULTURES | - |
| dc.subject.keywordPlus | EFFICIENCY PLANT-PRODUCTION | - |
| dc.subject.keywordPlus | CELL-SUSPENSION CULTURES | - |
| dc.subject.keywordPlus | KOREAN RED GINSENG | - |
| dc.subject.keywordPlus | SOMATIC EMBRYOGENESIS | - |
| dc.subject.keywordPlus | ADVENTITIOUS ROOTS | - |
| dc.subject.keywordPlus | SAPONIN PRODUCTION | - |
| dc.subject.keywordPlus | TISSUE-CULTURES | - |
| dc.subject.keywordAuthor | Panax | - |
| dc.subject.keywordAuthor | Ginsenosides | - |
| dc.subject.keywordAuthor | Tissue culture | - |
| dc.subject.keywordAuthor | Elicitor | - |
| dc.subject.keywordAuthor | Bioreactor | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
